Tekmira Conference Call and Webcast Advisory: Corporate Update and Year-End
2012 Financial Results
VANCOUVER, B.C., March 20, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals
Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference
(RNAi) therapeutics, announced that it will hold a conference call and webcast
on Wednesday, March 27, 2013 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to
provide a corporate update and report year-end 2012 financial results.
Conference Call and Webcast Information
A live webcast of the call can be accessed through the Investor section of
Tekmira's website at www.tekmirapharm.com. Or, alternatively, to access the
conference call, please dial 914-495-8556 or 1-866-393-1607.
An archived webcast will be available on the Tekmira website approximately two
hours after the event. Alternatively, to access a replay of the conference
call, please dial 404-537-3406 or 1-855-859-2056 and reference conference ID
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on
advancing novel RNAi therapeutics and providing its leading lipid nanoparticle
delivery technology to pharmaceutical partners. Tekmira has been working in
the field of nucleic acid delivery for over a decade and has broad
intellectual property covering LNPs. Further information about Tekmira can be
found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.
Director, Investor Relations
Longview Communications Inc.
Tekmira Pharmaceuticals Logo
Press spacebar to pause and continue. Press esc to stop.